TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
Provided By GlobeNewswire
Last update: Nov 13, 2025
MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the third quarter ended September 30, 2025.
Read more at globenewswire.com
